View all adult cancer types
View all pediatric cancer types
Susan F. Smith Center for Women's Cancers
Gynecologic CancerBlood CancersCancer Genetics and PreventionCutaneous (Skin) CancerGastrointestinal CancerGenitourinary CancerHead and Neck CancerHematologyMelanomaNeuro-OncologySarcomaStem Cell TransplantThoracic (Lung) Cancer
Blood DisordersBrain TumorsHematologic MalignanciesSolid TumorsStem Cell Transplant
Dana-Farber Cancer Institute has launched DiscoverCareBelieve.org, a new platform to illustrate what sets Dana-Farber apart — in research discovery... in expert, compassionate care... and in our strong belief in progress for people with cancer everywhere.WebsiteVideoWhat do you #DiscoverCareBelieve?
First study of the genomic composition of prostate cancer shows many patients have gene mutations that can be targeted with existing or potential drugs.
Clinicians at Dana-Farber/Brigham and Women'’s Cancer Center are now armed with specialized tests to create a precise "tumor profile" for each patient's cancer. Learn about the latest thinking in precision cancer medicine from our researchers and clinicians, and explore a searchable database of clinical trials that focus on targeted therapies by disease, gene, and mutation.
Study led by Dr. Jennifer Ligibel finds exercise programs can improve quality of life for cancer survivors.
In a new study published in Nature, Dana-Farber scientists demonstrate how a sudden, isolated shuffling of genetic material — known as chromothripsis — can occur.
A new technology developed at Dana-Farber may make it possible to target "undruggable" proteins and overcome drug resistance by using a cancer cell's own protein-degrading machinery to destroy, not just inhibit, cancer proteins.
Dr. Brian Alexander commented on glioblastoma, the aggressive form of cancer that killed Vice President Joe Biden's son.
Dr. David Reardon led a study, presented at the American Society of Clinical Oncology (ASCO) meeting, that found adding an experimental, which enlists the immune system to fight cancer to standard therapy, helped patients with the deadliest type of brain cancer live longer.
Dr. Pasi A. Janne commented on a new drug that unleashes the body's immune system to attack tumors, which can prolong the lives of people with the most common form of lung cancer.
Dr. Patrick Ott commented on the rapid rise of immunotherapy research.
Dr. Jennifer Ligibel co-led a study, presented at the 2015 Annual Meeting of the American Society of Clinical Oncology (ASCO),that evaluated cancer survivors for quality of life, physical activity and fitness. Additional authors of the study include Drs. Sara Tolaney, Erica Mayer, Rachel Yung and Rachel Freedman.
Dr. Irene Ghobrial discussed the role social media plays in healthcare and how a Facebook and Twitter post help recruit 200 patients for a clinical trial.
Dr. Jonathan Marron led a study that found it's better for
doctors to be open with parents about their child's cancer prognosis, even if
the news is bad.
Lymphoma Support Group
12:30 PM - 1:30 PM
Smith Building, Room 335
Lymphoma Support Group
Tai Chi for Optimal Health
3:00 PM - 4:30 PM
DA110 - Dana Bldg., 1st Floor, Room DA110
An internal Chinese martial art practiced for both defense training and health benefits. Learn sitting and standing techniques as well as slow moving meditation. Open to patients and family members. Please register at 617-632-3322.
4:30 PM - 6:00 PM
Fine tune your mind/body skills and create balance among them. Open to patients and family members. Please register at 617-632-3322.
Patient referral information, clinical resources and more.
For adults:877-442-3324Quick access: Appointments as soon as the next day for new adult patientsFor children:888-733-4662
Search current cancer clinical trials at Dana-Farber.
There are many ways to support Dana-Farber and the Jimmy Fund.
Top-ranked cancer center in New England for adults (with Brigham and Women's Hospital) — #1 in the nation for children (with Boston Children's Hospital)
Insight features the latest in cancer care and research news from Dana-Farber.Read the blog
Stay current on the latest news by signing up for Spotlight, our email newsletter.View current issueSubscribe now
Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215 | Call us toll-free: